Dermatomyositis Flare After a COVID-19 Infection Successfully Treated with Rituximab: A Case Report and Literature Review.
Ahmed Mohammed AlbakriAhmed Hussein SubkiAbdurahman AlbeityHussein HalabiPublished in: Journal of inflammation research (2022)
Exacerbation of dermatomyositis can be encountered following a COVID-19 infection, even if the infection is mild. Aggressive therapy should be considered in such cases. The prognosis, however, is generally favorable.
Keyphrases
- interstitial lung disease
- disease activity
- systemic sclerosis
- chronic obstructive pulmonary disease
- rheumatoid arthritis
- diffuse large b cell lymphoma
- idiopathic pulmonary fibrosis
- chronic lymphocytic leukemia
- stem cells
- intensive care unit
- acute respiratory distress syndrome
- respiratory failure
- replacement therapy